NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts $0.60 +0.01 (+2.04%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$0.60 0.00 (-0.67%) As of 04/17/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock NovaBay Pharmaceuticals Earnings Summary Upcoming Q3 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Aug. 13) -$1.37 Missed By -$1.37 Actual Revenue (Aug. 13) $2.40MNovaBay Pharmaceuticals announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$1.37. Quarterly revenue was reported to be $2.40 million. With a trailing EPS of -$9.95, NovaBay Pharmaceuticals' earnings are expected to grow next year, from ($2.54) to ($0.55) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q)NBY Upcoming EarningsNovaBay Pharmaceuticals' next earnings date is estimated for Thursday, May 8, 2025, based on past reporting schedules. Powered by Get NovaBay Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovaBay Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNBY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NBY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NovaBay Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($2.54) EPSNext Year EPS Consensus Estimate ($0.55) EPS NovaBay Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------8/13/2024Q2 2024--$1.37 -$1.37-$1.37-$2.40M5/9/2024Q1 2024--$0.14 -$0.14-$0.13-$2.63M3/26/2024Q4 2023--$0.95 -$0.95-$0.57-$3.73M11/9/2023Q3 2023--$0.37 -$0.37-$0.37-$3.27M8/10/2023Q2 2023--$1.27 -$1.27-$1.27-$4.61M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M Get the Latest News and Ratings for NBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M NovaBay Pharmaceuticals Earnings - Frequently Asked Questions When is NovaBay Pharmaceuticals's earnings date? NovaBay Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on NBY's earnings history. How can I listen to NovaBay Pharmaceuticals's earnings conference call? The conference call for NovaBay Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read NovaBay Pharmaceuticals's conference call transcript? The conference call transcript for NovaBay Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does NovaBay Pharmaceuticals generate each year? NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded annual revenue of $14.40 million. How much profit does NovaBay Pharmaceuticals generate each year? NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded net income of -$10.61 million. NBY has generated -$9.95 earnings per share over the last four quarters. What is NovaBay Pharmaceuticals's EPS forecast for next year? NovaBay Pharmaceuticals's earnings are expected to grow from ($2.54) per share to ($0.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies CHRO Earnings KPRX Earnings NEUP Earnings AIMD Earnings BLRX Earnings CARM Earnings BCLI Earnings BETRF Earnings ADXN Earnings ACXP Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NYSEAMERICAN:NBY) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NBY Stock Free NBY Stock Alerts